BACKGROUND: Pneumonia contributes substantially to childhood mortality in Bangladesh. We conducted a study to characterize the disease severity and risk factors for mortality among children hospitalized for pneumonia in Bangladesh. METHODS: We analyzed data on hospitalization, patient characteristics, and mortality collected by a multicenter hospital-based surveillance of pneumonia in Bangladesh. RESULTS: From May 2004 through April 2007, 4155 children aged 2-59 months who met a pneumonia case definition adopted by GAVI's Pneumococcal Vaccines Accelerated Development and Introduction Plan-sponsored surveillance networks were enrolled after blood culture specimens were obtained. The mean duration (+/-SD) from illness onset to hospital admission was 6+/- days; 1842 children (44%) received antimicrobial treatment before hospitalization, and an additional 924 (22%) received antimicrobial treatment after admission to the hospital. Bacteria were isolated from 161 (4%) of the 4155 specimens, including 10 (6%) Streptococcus pneumoniae isolates and 5 (3%) Haemophilus influenzae type b isolates. The case-fatality rate for pneumonia in the hospital was 4% (150 deaths), and the children who died did so after a median of 2 days of hospitalization (range, 0-24 days). Infancy was highly associated with death due to pneumonia (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.3-3.2), as were very severe pneumonia (OR, 7.9; 95% CI, 5.6-11.2), a blood culture positive for bacteria (OR, 3.4; 95% CI, 2.0-5.8), severe malnutrition (OR, 4.6; 95% CI, 2.9-7.4), and delayed admission (mean [+/-SD] duration from illness onset to admission, 6+/-6 days, compared with 5+/-4 days for survivors; P< .04). CONCLUSIONS: The prevalence of pneumonia among children aged <5 years in hospitals in Bangladesh is high. However, the isolation rate of bacteria is low, possibly because of the high (68%) background use of antibiotics. Multiple risk factors associated with pneumonia case fatality suggest multiple strategies, including vaccines, to reduce pneumonia-related and overall child mortality in Bangladesh.
BACKGROUND:Pneumonia contributes substantially to childhood mortality in Bangladesh. We conducted a study to characterize the disease severity and risk factors for mortality among children hospitalized for pneumonia in Bangladesh. METHODS: We analyzed data on hospitalization, patient characteristics, and mortality collected by a multicenter hospital-based surveillance of pneumonia in Bangladesh. RESULTS: From May 2004 through April 2007, 4155 children aged 2-59 months who met a pneumonia case definition adopted by GAVI's Pneumococcal Vaccines Accelerated Development and Introduction Plan-sponsored surveillance networks were enrolled after blood culture specimens were obtained. The mean duration (+/-SD) from illness onset to hospital admission was 6+/- days; 1842 children (44%) received antimicrobial treatment before hospitalization, and an additional 924 (22%) received antimicrobial treatment after admission to the hospital. Bacteria were isolated from 161 (4%) of the 4155 specimens, including 10 (6%) Streptococcus pneumoniae isolates and 5 (3%) Haemophilus influenzae type b isolates. The case-fatality rate for pneumonia in the hospital was 4% (150 deaths), and the children who died did so after a median of 2 days of hospitalization (range, 0-24 days). Infancy was highly associated with death due to pneumonia (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.3-3.2), as were very severe pneumonia (OR, 7.9; 95% CI, 5.6-11.2), a blood culture positive for bacteria (OR, 3.4; 95% CI, 2.0-5.8), severe malnutrition (OR, 4.6; 95% CI, 2.9-7.4), and delayed admission (mean [+/-SD] duration from illness onset to admission, 6+/-6 days, compared with 5+/-4 days for survivors; P< .04). CONCLUSIONS: The prevalence of pneumonia among children aged <5 years in hospitals in Bangladesh is high. However, the isolation rate of bacteria is low, possibly because of the high (68%) background use of antibiotics. Multiple risk factors associated with pneumonia case fatality suggest multiple strategies, including vaccines, to reduce pneumonia-related and overall child mortality in Bangladesh.
Authors: Anna Bellos; Kim Mulholland; Katherine L O'Brien; Shamim A Qazi; Michelle Gayer; Francesco Checchi Journal: Confl Health Date: 2010-02-11 Impact factor: 2.723
Authors: Kathleen F Cavallaro; Hardeep S Sandhu; Terri B Hyde; Barbara W Johnson; Marc Fischer; Leonard W Mayer; Thomas A Clark; Mark A Pallansch; Zundong Yin; Shuyan Zuo; Stephen C Hadler; Serguey Diorditsa; A S M Mainul Hasan; Anindya S Bose; Vance Dietz Journal: Vaccine Date: 2015-01-15 Impact factor: 3.641
Authors: Zunera Gilani; Yuenting D Kwong; Orin S Levine; Maria Deloria-Knoll; J Anthony G Scott; Katherine L O'Brien; Daniel R Feikin Journal: Clin Infect Dis Date: 2012-04 Impact factor: 9.079
Authors: Emily S Gurley; Shahana Parveen; M Saiful Islam; M Jahangir Hossain; Nazmun Nahar; Nusrat Homaira; Rebeca Sultana; James J Sejvar; Mahmudur Rahman; Stephen P Luby Journal: BMC Med Ethics Date: 2011-06-13 Impact factor: 2.652
Authors: Samir K Saha; Hassan M Al Emran; Belal Hossain; Gary L Darmstadt; Senjuti Saha; Maksuda Islam; Atique I Chowdhury; Dona Foster; Aliya Naheed; Shams El Arifeen; Abdullah H Baqui; Shamim A Qazi; Stephen P Luby; Robert F Breiman; Mathuram Santosham; Robert E Black; Derrick W Crook Journal: PLoS One Date: 2012-03-30 Impact factor: 3.240
Authors: Sharifa Nasreen; Stephen P Luby; W Abdullah Brooks; Nusrat Homaira; Abdullah Al Mamun; Mejbah Uddin Bhuiyan; Mustafizur Rahman; Dilruba Ahmed; Jaynal Abedin; Mahmudur Rahman; A S M Alamgir; Alicia M Fry; Peter Kim Streatfield; Anisur Rahman; Joseph Bresee; Marc-Alain Widdowson; Eduardo Azziz-Baumgartner Journal: PLoS One Date: 2014-02-25 Impact factor: 3.240